Have a personal or library account? Click to login
Characterization of OXA232-Producing Carbapenem-Resistant Klebsiella pneumoniae: Genomic Analysis and Virulence Assessment Cover

Characterization of OXA232-Producing Carbapenem-Resistant Klebsiella pneumoniae: Genomic Analysis and Virulence Assessment

Open Access
|Mar 2025

References

  1. Abdul Momin MHF, Liakopoulos A, Phee LM, Wareham DW. Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam. J Glob Antimicrob Resist. 2017 Jun;9:96–99. https://doi.org/10.1016/j.jgar.2017.02.008
  2. Aslan AT, Kırbaş E, Sancak B, Tanrıverdi ES, Otlu B, Gürsoy NC, Yılmaz YA, Tozluyurt A, Liste Ü, Bıçakcıgil A, et al; Study Group for Carbapenem Resistance (SCARE). A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting. Int J Antimicrob Agents. 2022 Apr; 59(4):106554. https://doi.org/10.1016/j.ijantimicag.2022.106554
  3. Bachman MA, Lenio S, Schmidt L, Oyler JE, Weiser JN. Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. mBio. 2012 Nov;3(6):e00224-11. https://doi.org/10.1128/mBio.00224-11
  4. Bachman MA, Miller VL, Weiser JN. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog. 2009 Oct;5(10):e1000622. https://doi.org/10.1371/journal.ppat.1000622
  5. Boyd SE, Holmes A, Peck R, Livermore DM, Hope W. OXA-48-like β-lactamases: Global epidemiology, treatment options, and development pipeline. Antimicrob Agents Chemother. 2022 Aug; 66(8):e0021622. https://doi.org/10.1128/aac.00216-22
  6. Cerón S, Salem-Bango Z, Contreras DA, Ranson EL, Yang S. Clinical and genomic characterization of carbapenem-resistant Klebsiella pneumoniae with concurrent production of NDM and OXA-48-like carbapenemases in Southern California, 2016–2022. Microorganisms. 2023 Jun;11(7):1717. https://doi.org/10.3390/microorganisms11071717
  7. Chen T, Xu H, Chen Y, Ji J, Ying C, Liu Z, Xu H, Zhou K, Xiao Y, Shen P. Identification and characterization of OXA-232-producing sequence Type 231 multidrug resistant Klebsiella pneumoniae strains causing bloodstream infections in China. Microbiol Spectr. 2023 Mar;11(2):e0260722. https://doi.org/10.1128/spectrum.02607-22
  8. Chen Y, Fang L, Yang Y, Yan R, Fu Y, Shen P, Zhao D, Chen Y, Hua X, Jiang Y, et al. Emergence of carbapenem-resistant Klebsiella pneumoniae harbouring blaOXA-48-like genes in China. J Med Microbiol. 2021 Mar;70(3):001306. https://doi.org/10.1099/jmm.0.001306
  9. Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, Jenney A, Connor TR, Hsu LY, Severin J, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci USA. 2015 Jul;112(27):E3574-E3581. https://doi.org/10.1073/pnas.1501049112
  10. Idriss HT, Naismith JH. TNFα and the TNF receptor superfamily: Structure-function relationship(s). Microsc Res Tech. 2000 Aug; 50(3):184–195. https://doi.org/10.1002/1097-0029(20000801)50:3<;184::AID-JEMT2>3.0.CO;2-H
  11. Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021 Jun;25:26–34. https://doi.org/10.1016/j.jgar.2021.02.020
  12. Lee BE, Seol HY, Kim TK, Seong EY, Song SH, Lee DW, Lee SB, Kwak IS. Recent clinical overview of renal and perirenal abscesses in 56 consecutive cases. Korean J Intern Med. 2008 Sep;23(3):140–148. https://doi.org/10.3904/kjim.2008.23.3.140
  13. Lutgring JD, Zhu W, de Man TJB, Avillan JJ, Anderson KF, Lonsway DR, Rowe LA, Batra D, Rasheed JK, Limbago BM. Phenotypic and Genotypic characterization of Enterobacteriaceae producing oxacillinase-48-like carbapenemases, United States. Emerg Infect Dis. 2018 Apr;24(4):700–709. https://doi.org/10.3201/eid2404.171377
  14. Mancini S, Poirel L, Tritten ML, Lienhard R, Bassi C, Nordmann P. Emergence of an MDR Klebsiella pneumoniae ST231 producing OXA-232 and RmtF in Switzerland. J Antimicrob Chemother. 2018 Mar;73(3):821–823. https://doi.org/10.1093/jac/dkx428
  15. Mehrotra T, Konar D, Pragasam AK, Kumar S, Jana P, Babele P, Paul D, Purohit A, Tanwar S, Bakshi S, et al. Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis. Proc Natl Acad Sci USA. 2023 Aug;120(33):e2305465120. https://doi.org/10.1073/pnas.2305465120
  16. Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacil-linase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004 Jan;48(1):15–22. https://doi.org/10.1128/aac.48.1.15-22.2004
  17. Potron A, Rondinaud E, Poirel L, Belmonte O, Boyer S, Camiade S, Nordmann P. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Entero-bacteriaceae. Int J Antimicrob Agents. 2013 Apr;41(4):325–329. https://doi.org/10.1016/j.ijantimicag.2012.11.007
  18. Qian C, Zhang S, Xu M, Zeng W, Chen L, Zhao Y, Zhou C, Zhang Y, Cao J, Zhou T. Genetic and phenotypic characterization of multidrug-resistant Klebsiella pneumoniae from liver abscess. Microbiol Spectr. 2023 Feb;11(1):e0224022. https://doi.org/10.1128/spectrum.02240-22
  19. Shankar C, Basu S, Lal B, Shanmugam S, Vasudevan K, Mathur P, Ramaiah S, Anbarasu A, Veeraraghavan B. Aerobactin seems to be a promising marker compared with unstable RmpA2 for the identification of hypervirulent carbapenem-resistant Klebsiella pneumoniae: In silico and in vitro evidence. Front Cell Infect Microbiol. 2021 Sep; 11:709681. https://doi.org/10.3389/fcimb.2021.709681
  20. Shankar C, Mathur P, Venkatesan M, Pragasam AK, Anandan S, Khurana S, Veeraraghavan B. Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: Multiple and varied mobile genetic elements. BMC Microbiol. 2019 Jun; 19(1):137. https://doi.org/10.1186/s12866-019-1513-8
  21. Shen S, Han R, Yin D, Jiang B, Ding L, Guo Y, Wu S, Wang C, Zhang H, Hu F. A nationwide genomic study of clinical Klebsiella pneumoniae carrying blaOXA-232 and rmtF in China. Microbiol Spectr. 2023 Jun;11(3):e0386322. https://doi.org/10.1128/spectrum.03863-22
  22. Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol. 2021 Dec; 101(Pt_B):107598. https://doi.org/10.1016/j.intimp.2021.107598
  23. Singh S, Pathak A, Fatima N, Sahu C, Prasad KN. Characterisation of OXA-48-like carbapenemases in Escherichia coli and Klebsiella pneumoniae from North India. 3 Biotech. 2023 May;13(5):134. https://doi.org/10.1007/s13205-023-03537-8
  24. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014 Sep;6(10): a016295. https://doi.org/10.1101/cshperspect.a016295
  25. Wu Y, Jiang T, He X, Shao J, Wu C, Mao W, Jia H, He F, Kong Y, Wu J, et al. Global phylogeography and genomic epidemiology of carbapenem-resistant blaOXA-232-carrying Klebsiella pneumoniae sequence type 15 lineage. Emerg Infect Dis. 2023 Nov;29(11):2246– 2256. https://doi.org/10.3201/eid2911.230463
  26. Wyres KL, Nguyen TNT, Lam MMC, Judd LM, van Vinh Chau N, Dance DAB, Ip M, Karkey A, Ling CL, Miliya T, et al. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med. 2020 Jan;12(1):11. https://doi.org/10.1186/s13073-019-0706-y
DOI: https://doi.org/10.33073/pjm-2025-007 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 82 - 94
Submitted on: Nov 12, 2024
|
Accepted on: Jan 24, 2025
|
Published on: Mar 26, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Zhouxun Li, Chunyan Wu, Xuemei Cai, Yongli Song, Xingping Zheng, Yuan He, Guibo Song, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.